BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 3457264)

  • 1. Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia.
    Talpaz M; Kantarjian HM; McCredie K; Trujillo JM; Keating MJ; Gutterman JU
    N Engl J Med; 1986 Apr; 314(17):1065-9. PubMed ID: 3457264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in granulocyte-monocyte colony-forming cells among leukocyte-interferon-treated chronic myelogenous leukemia patients.
    Talpaz M; Spitzer G; Hittelman W; Kantarjian H; Gutterman J
    Exp Hematol; 1986 Aug; 14(7):668-71. PubMed ID: 3460811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical investigation of interferons in the preleukemic state (CML and MDS)].
    Koyama S
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1191-7. PubMed ID: 3132893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical investigation of human alpha interferon in chronic myelogenous leukemia.
    Talpaz M; Kantarjian HM; McCredie KB; Keating MJ; Trujillo J; Gutterman J
    Blood; 1987 May; 69(5):1280-8. PubMed ID: 3471281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collection of Philadelphia-negative stem cells using recombinant human granulocyte colony-stimulating factor in chronic myeloid leukemia patients treated with alpha-interferon.
    Hernández-Boluda JC; Carreras E; Cervantes F; Marín P; Arellano-Rodrigo E; Rovira M; Solé F; Lloveras E; Espinet B; Ocejo A; Montserrat E
    Haematologica; 2002 Jan; 87(1):17-22. PubMed ID: 11801461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [alpha 2-interferon: preliminary treatment results in chronic myeloid leukemia].
    Niederle N; Kloke O; Doberauer C; Becher R; Beelen DW; Schmidt CG
    Dtsch Med Wochenschr; 1986 May; 111(20):767-72. PubMed ID: 3516621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interferon in the eradication of the Philadelphia chromosome in chronic myeloid leukemia].
    Arana-Trejo RM; Ovilla-Martínez R; Gómez-Morales E; Meillon-García L; Cervantes-Peredo A; González-Llaven J; Pizzuto-Chávez J; Kofman-Alfaro S
    Rev Invest Clin; 1997; 49(3):209-14. PubMed ID: 9380976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease.
    Posthuma EF; Marijt EW; Barge RM; van Soest RA; Baas IO; Starrenburg CW; van Zelderen-Bhola SL; Fibbe WE; Smit WM; Willemze R; Falkenburg JH
    Biol Blood Marrow Transplant; 2004 Mar; 10(3):204-12. PubMed ID: 14993886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group.
    Ohnishi K; Minami S; Ueda T; Nishimura M; Tsubaki K; Takemoto Y; Takeshita A; Sao H; Kageyama S; Ueda R; Ohno R
    Int J Hematol; 2000 Aug; 72(2):229-36. PubMed ID: 11039674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
    Carella AM; Chimirri F; Podestà M; Pitto A; Piaggio G; Dejana A; Lerma E; Pollicardo N; Vassallo F; Soracco M; Benvenuto F; Valbonesi M; Carlier P; Vimercati R; Prencipe E; Gatti AM; Ferrara RA; Incagliato M; Florio G; Frassoni F
    Bone Marrow Transplant; 1996 Feb; 17(2):201-5. PubMed ID: 8640167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of long-term marrow culture on the nonadherent Philadelphia chromosome-positive clone in chronic myelogenous leukemia: preliminary observations.
    O'Brien S; Kantarjian HM; Talpaz M; Cork A; Trujillo J; Beran M
    Hematol Pathol; 1987; 1(3):167-72. PubMed ID: 3509052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I-II study of continuous-infusion high-dose human lymphoblastoid interferon and the in vitro sensitivity of leukemic progenitors in nonlymphocytic leukemia.
    Mirro J; Dow LW; Kalwinsky DK; Dahl GV; Weck P; Whisnant J; Murphy SB
    Cancer Treat Rep; 1986 Mar; 70(3):363-7. PubMed ID: 3456833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of alpha-interferon and autologous bone marrow transplantation in chronic myeloid leukemia. The Italian Co-operative Study Group on Chronic Myeloid Leukemia.
    Meloni G; Russo D; Baccarani M; Testoni N; Martinelli G; Fanin R; Zuffa E; Rosti G; Alimena G; Saglio G; Mandelli F; Tura S
    Haematologica; 1999 Aug; 84(8):707-15. PubMed ID: 10457406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant alpha-2 interferon in the treatment of hairy cell leukemia.
    Thompson JA; Brady J; Kidd P; Fefer A
    Cancer Treat Rep; 1985; 69(7-8):791-3. PubMed ID: 4016788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon alfa-2b in the treatment of chronic myelogenous leukemia.
    Niederle N; Kloke O; Osieka R; Wandl U; Opalka B; Schmidt CG
    Semin Oncol; 1987 Jun; 14(2 Suppl 2):29-35. PubMed ID: 3473689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Natural interferon alpha for chronic myelogenous leukemia in the chronic phase: hematologic, cytogenetic and molecular response].
    Takeuchi J; Kawamura M; Sawada U; Ohshima T; Horie T; Horikoshi A; Abe T
    Rinsho Ketsueki; 1995 Oct; 36(10):1149-56. PubMed ID: 8531323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant alpha-interferon (alpha-IFN) for progressive hairy-cell leukemia (HCL): a study in previously untreated nonsplenectomized patients.
    Schwarzinger I; Bettelheim P; Chott A; Herold C; Hinterberger W; Köller U; Kos M; Neumann E; Radaszkiewicz T; Lechner K
    Wien Klin Wochenschr; 1988 Jan; 100(2):47-51. PubMed ID: 3348041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon alpha-2b as therapy for Ph'-positive chronic myelogenous leukemia: a study of 82 patients treated with intermittent or daily administration.
    Alimena G; Morra E; Lazzarino M; Liberati AM; Montefusco E; Inverardi D; Bernasconi P; Mancini M; Donti E; Grignani F
    Blood; 1988 Aug; 72(2):642-7. PubMed ID: 3165298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic myelogenous leukaemia: haematological remissions with alpha interferon.
    Talpaz M; McCredie K; Kantarjian H; Trujillo J; Keating M; Gutterman J
    Br J Haematol; 1986 Sep; 64(1):87-95. PubMed ID: 3463363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid improvement in a terminal case of hairy cell leukemia treated with a new human recombinant interferon, IFN-alpha-C.
    Aderka D; Levo Y; Rahmani R; Mory Y; Vaks B; Horowitz O; Doerner T; Shoham J; Wallach D; Revel M
    Isr J Med Sci; 1985 Dec; 21(12):977-81. PubMed ID: 4093298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.